Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer

Urology

Volumn 68, Issue 3, 2006, Pages 593-598

  Kupelian, Patrick A ^a   Mahadevan, Arul ^b   Reddy, Chandana A ^b   Reuther, Alwyn M ^b   Klein, Eric A ^b  

^a M D ANDERSON CANCER CENTER ORLANDO   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BIOCHEMISTRY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; ONCOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOCARCINOMA; DISEASE-FREE SURVIVAL; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TERMINOLOGY; TREATMENT FAILURE;

EID: 33748923481     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.03.075     Document Type: Article

References (22)

1. Paulson D.F. Radiotherapy versus surgery for localized prostatic cancer. Urol Clin North Am 14 (1987) 675-684
2. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
3. Kupelian P.A., Elshaikh M., Reddy C.A., et al. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. J Clin Oncol 20 (2002) 3376-3385
4. Kupelian P.A., Potters L., Khuntia D., et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 25-33
5. Potters L., Klein E.A., Kattan M.W., et al. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71 (2004) 29-33
6. D'Amico A.V., Whittington R., Kaplan I., et al. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of >4-20 ng/ml. Int J Radiat Oncol Biol Phys 37 (1997) 1053-1058
7. Horwitz E.M., Thames H.D., Kuban D.A., et al. Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. J Urol 173 (2005) 797-802
8. Kestin L.L., Vicini F.A., and Martinez A.A. Practical application of biochemical failure definitions: what to do and when to do it. Int J Radiat Oncol Biol Phys 53 (2002) 304-315
9. Kuban D., Thames H., Levy L., et al. Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?. Int J Radiat Oncol Biol Phys 61 (2005) 409-414
10. Kupelian P.A., Mohan D.S., Lyons J., et al. Higher than standard radiation doses (72 Gy or greater) with or without androgen deprivation in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 46 (2000) 567-574
11. Lyons J.A., Kupelian P.A., Mohan D.S., et al. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. Urology 55 (2000) 85-90
12. Cagiannos I., Karakiewicz P., Graefen M., et al. Is year of radical prostatectomy a predictor of outcome in prostate cancer?. J Urol 171 (2004) 692-696
13. Jhaveri F.M., Klein E.A., Kupelian P.A., et al. Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. J Clin Oncol 17 (1999) 3167-3172
14. Kupelian P., Thames H., Levy L., et al. Year of treatment as an independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 63 (2005) 795-799
15. D'Amico A., Whittington R., Malkowicz S., et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol 154 (1995) 131-138
16. D'Amico A.V. How to compare results after surgery or radiation for localized prostate carcinoma. Cancer 95 (2002) 2041-2043
17. Klein E.A. Radiation therapy versus radical prostatectomy in the PSA era: a urologist's view. Semin Radiat Oncol 8 (1998) 87-94
18. Horwitz E.M., Uzzo R.G., Hanlon A.L., et al. Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone. J Urol 169 (2003) 2153-2157
19. Bianco Jr. F.J., Scardino P.T., Stephenson A.J., et al. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 448-453
20. Stephenson A.J., Scardino P.T., Bianco Jr. F.J., et al. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172 (2004) 2239-2243
21. Stephenson A.J., Scardino P.T., Bianco Jr. F.J., et al. Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy. Curr Treat Options Oncol 5 (2004) 357-365
22. Messing E.M., Manola J., Sarosdy M., et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341 (1999) 1781-1788